Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference. 

<p>Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference.&nbsp;</p>

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

<p>Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.</p>

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Mike Doustdar Talks Strong Demand for Weight Loss Pills

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b653fc15-c4aa-4547-a7b7-b3d1016f9887/transcript